323 related articles for article (PubMed ID: 21092288)
21. Hypofractionated Versus Conventional Fractionated Radiotherapy After Breast-Conserving Surgery in the Modern Treatment Era: A Multicenter, Randomized Controlled Trial From China.
Wang SL; Fang H; Hu C; Song YW; Wang WH; Jin J; Liu YP; Ren H; Liu J; Li GF; Du XH; Tang Y; Jing H; Ma YC; Huang Z; Chen B; Tang Y; Li N; Lu NN; Qi SN; Yang Y; Sun GY; Liu XF; Li YX
J Clin Oncol; 2020 Nov; 38(31):3604-3614. PubMed ID: 32780661
[TBL] [Abstract][Full Text] [Related]
22. Hypofractionated whole breast radiotherapy with or without hypofractionated boost in early stage breast cancer patients: a mono-institutional analysis of skin and subcutaneous toxicity.
Palumbo I; Mariucci C; Falcinelli L; Perrucci E; Lancellotta V; Podlesko AM; Marcantonini M; Saldi S; Bini V; Aristei C
Breast Cancer; 2019 May; 26(3):290-304. PubMed ID: 30341747
[TBL] [Abstract][Full Text] [Related]
23. Final analysis of a Multicenter Single-Arm Confirmatory Trial of hypofractionated whole breast irradiation after breast-conserving surgery in Japan: JCOG0906.
Nozaki M; Kagami Y; Machida R; Nakamura K; Ito Y; Nishimura Y; Teshima T; Saito Y; Nagata Y; Matsumoto Y; Akimoto T; Hiraoka M;
Jpn J Clin Oncol; 2021 May; 51(6):865-872. PubMed ID: 33728450
[TBL] [Abstract][Full Text] [Related]
24. Once-Weekly Hypofractionated Whole-Breast Radiotherapy After Breast-Conserving Surgery in Older Patients: A Potential Alternative Treatment Schedule to Daily 3-Week Hypofractionation.
Rovea P; Fozza A; Franco P; De Colle C; Cannizzaro A; Di Dio A; De Monte F; Rosmino C; Filippi AR; Ragona R; Ricardi U
Clin Breast Cancer; 2015 Aug; 15(4):270-6. PubMed ID: 25666079
[TBL] [Abstract][Full Text] [Related]
25. Hypofractionated Versus Standard Fractionated Radiotherapy in Patients With Early Breast Cancer or Ductal Carcinoma In Situ in a Randomized Phase III Trial: The DBCG HYPO Trial.
Offersen BV; Alsner J; Nielsen HM; Jakobsen EH; Nielsen MH; Krause M; Stenbygaard L; Mjaaland I; Schreiber A; Kasti UM; Overgaard J;
J Clin Oncol; 2020 Nov; 38(31):3615-3625. PubMed ID: 32910709
[TBL] [Abstract][Full Text] [Related]
26. Two hypofractionated schedules for early stage breast cancer: Comparative retrospective analysis for acute and late radiation induced dermatitis.
Zygogianni A; Gogalis J; Georgakopoulos I; Nikoloudi S; Liakouli Z; Kougioumtzopoulou A; Alexiou D; Antypas C; Armpilia C; Protopapa M; Moulopoulou LA; Kouloulias V
J BUON; 2020; 25(3):1315-1322. PubMed ID: 32862571
[TBL] [Abstract][Full Text] [Related]
27. Evidence from a breast cancer hypofractionated schedule: late skin toxicity assessed by ultrasound.
Landoni V; Giordano C; Marsella A; Saracino B; Petrongari M; Ferraro A; Strigari L; Pinnarò P
J Exp Clin Cancer Res; 2013 Oct; 32(1):80. PubMed ID: 24423027
[TBL] [Abstract][Full Text] [Related]
28. Hypofractionated radiotherapy with concomitant boost for breast cancer: a dose escalation study.
Ippolito E; Rinaldi CG; Silipigni S; Greco C; Fiore M; Sicilia A; Trodella L; D'Angelillo RM; Ramella S
Br J Radiol; 2019 Mar; 92(1095):20180169. PubMed ID: 30433824
[TBL] [Abstract][Full Text] [Related]
29. Late effects and cosmetic results of conventional versus hypofractionated irradiation in breast-conserving therapy.
Fehlauer F; Tribius S; Alberti W; Rades D
Strahlenther Onkol; 2005 Oct; 181(10):625-31. PubMed ID: 16220400
[TBL] [Abstract][Full Text] [Related]
30. Toxicity and cosmetic outcome of hypofractionated whole-breast radiotherapy: predictive clinical and dosimetric factors.
Ciammella P; Podgornii A; Galeandro M; Micera R; Ramundo D; Palmieri T; Cagni E; Iotti C
Radiat Oncol; 2014 Apr; 9():97. PubMed ID: 24762173
[TBL] [Abstract][Full Text] [Related]
31. Adjuvant hypofractionated radiation therapy for breast cancer after conserving surgery.
Livi L; Stefanacci M; Scoccianti S; Dicosmo D; Borghesi S; Nosi F; Simontacchi G; Mangoni M; Paiar F; Ponticelli P; Nori J; Chiavacci A; Biti GP
Clin Oncol (R Coll Radiol); 2007 Mar; 19(2):120-4. PubMed ID: 17355107
[TBL] [Abstract][Full Text] [Related]
32. Accelerated hypofractionated radiotherapy schedules in breast cancer: a review of the current literature.
Kalogeridi MA; Kelekis N; Kouvaris J; Platoni K; Kyrias G; Pectasides D; Kouloulias V
Rev Recent Clin Trials; 2009 Sep; 4(3):147-51. PubMed ID: 20028324
[TBL] [Abstract][Full Text] [Related]
33. Acute radiation dermatitis and pneumonitis in Japanese breast cancer patients with whole breast hypofractionated radiotherapy compared to conventional radiotherapy.
Osako T; Oguchi M; Kumada M; Nemoto K; Iwase T; Yamashita T
Jpn J Clin Oncol; 2008 May; 38(5):334-8. PubMed ID: 18417501
[TBL] [Abstract][Full Text] [Related]
34. Relation between Hypofractionated Radiotherapy, Toxicity and Outcome in Early Breast Cancer.
De Felice F; Ranalli T; Musio D; Lisi R; Rea F; Caiazzo R; Tombolini V
Breast J; 2017 Sep; 23(5):563-568. PubMed ID: 28252236
[TBL] [Abstract][Full Text] [Related]
35. A Comparative Study of Daily 3-Gy Hypofractionated and 1.8-Gy Conventional Breast Irradiation in Early-Stage Breast Cancer.
Lee SW; Kim YJ; Shin KH; Kim K; Chie EK; Han W; Im SA; Jung SY; Lee KS; Lee ES
Medicine (Baltimore); 2016 May; 95(19):e3320. PubMed ID: 27175630
[TBL] [Abstract][Full Text] [Related]
36. Ultra-hypofractionated versus conventionally fractionated radiotherapy for prostate cancer: 5-year outcomes of the HYPO-RT-PC randomised, non-inferiority, phase 3 trial.
Widmark A; Gunnlaugsson A; Beckman L; Thellenberg-Karlsson C; Hoyer M; Lagerlund M; Kindblom J; Ginman C; Johansson B; Björnlinger K; Seke M; Agrup M; Fransson P; Tavelin B; Norman D; Zackrisson B; Anderson H; Kjellén E; Franzén L; Nilsson P
Lancet; 2019 Aug; 394(10196):385-395. PubMed ID: 31227373
[TBL] [Abstract][Full Text] [Related]
37. Hypofractionated radiation therapy for breast cancer: long-term results in a series of 85 patients.
Deantonio L; Cozzi S; Tunesi S; Brambilla M; Masini L; Pisani C; Gambaro G; Magnani C; Krengli M
Tumori; 2016 Aug; 102(4):398-403. PubMed ID: 27230276
[TBL] [Abstract][Full Text] [Related]
38. Ten-year results of accelerated hypofractionated adjuvant whole-breast radiation with concomitant boost to the lumpectomy cavity after conserving surgery for early breast cancer.
Cante D; Petrucci E; Sciacero P; Piva C; Ferrario S; Bagnera S; Patania S; Mondini G; Pasquino M; Casanova Borca V; Vellani G; La Porta MR; Franco P
Med Oncol; 2017 Sep; 34(9):152. PubMed ID: 28776318
[TBL] [Abstract][Full Text] [Related]
39. Higher-than-expected severe (Grade 3-4) late urinary toxicity after postprostatectomy hypofractionated radiotherapy: a single-institution analysis of 1176 patients.
Cozzarini C; Fiorino C; Deantoni C; Briganti A; Fodor A; La Macchia M; Noris Chiorda B; Rancoita PM; Suardi N; Zerbetto F; Calandrino R; Montorsi F; Di Muzio N
Eur Urol; 2014 Dec; 66(6):1024-30. PubMed ID: 24985964
[TBL] [Abstract][Full Text] [Related]
40. [Radiotherapy of breast cancer].
Hennequin C; Barillot I; Azria D; Belkacémi Y; Bollet M; Chauvet B; Cowen D; Cutuli B; Fourquet A; Hannoun-Lévi JM; Leblanc M; Mahé MA
Cancer Radiother; 2016 Sep; 20 Suppl():S139-46. PubMed ID: 27522187
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
